Maillard Lab
@maillardlab.bsky.social
Congratulations to the organisers on a fantastic EMBO Workshop in Leiden and now this excellent report in Nature Immunology. Thank you for the mention of our talk on improving self-amplifying mRNA vaccine efficiency, it was a pleasure to present at such an exciting event. Looking forward to 2028!
The EMBO Workshop "#PathogenImmunity and Signaling" that took place in Leiden, the Netherlands this year, brought together 175 participants from 25 countries. 🧪
A report in Nature Immunology summarizes the meeting:
https://www.nature.com/articles/s41590-026-02657-6
A report in Nature Immunology summarizes the meeting:
https://www.nature.com/articles/s41590-026-02657-6
New frontiers in pathogen immunity - Nature Immunology
The EMBO workshop ‘Pathogen Immunity and Signaling’ was held from 8 to 11 June 2026 in Leiden, the Netherlands, bringing together 175 participants from 25 countries to discuss the latest advances in antimicrobial immune defense.
www.nature.com
September 17, 2026 at 9:58 AM
Congratulations to the organisers on a fantastic EMBO Workshop in Leiden and now this excellent report in Nature Immunology. Thank you for the mention of our talk on improving self-amplifying mRNA vaccine efficiency, it was a pleasure to present at such an exciting event. Looking forward to 2028!
Better late than never, I have only recently joined Bluesky! Delighted that this study is now published in Nature Communications ! 🎉
Led by James Holt, a collaboration between the lab of Prof. Helen Rowe and mine, revealing epigenetic control of innate immunity in early development. 👇
Led by James Holt, a collaboration between the lab of Prof. Helen Rowe and mine, revealing epigenetic control of innate immunity in early development. 👇
doi: doi.org/10.1038/s414...
📣 Our study is now out in Nature Communications detailing that the type I interferon pathway is suppressed by HUSH in early human development: Its complete epigenetic lockdown!! Incredible work from James Holt 📣 😎
📣 Our study is now out in Nature Communications detailing that the type I interferon pathway is suppressed by HUSH in early human development: Its complete epigenetic lockdown!! Incredible work from James Holt 📣 😎
September 14, 2026 at 1:07 PM
Better late than never, I have only recently joined Bluesky! Delighted that this study is now published in Nature Communications ! 🎉
Led by James Holt, a collaboration between the lab of Prof. Helen Rowe and mine, revealing epigenetic control of innate immunity in early development. 👇
Led by James Holt, a collaboration between the lab of Prof. Helen Rowe and mine, revealing epigenetic control of innate immunity in early development. 👇